U.S. investors, Big Pharma race to find new medicines in China
A little-known biotech company stunned the biopharmaceutical industry last spring when it declared an “unprecedented” achievement: its experimental cancer drug looked more effective than Merck‘s Keytruda in a clinical trial. The company, Summit Therapeutics, licensed the drug from Chinese company Akeso Inc. In October, a group of life science investors announced they were putting $400 […]
U.S. investors, Big Pharma race to find new medicines in China Read More »